Lucey MR - Search Results

1

Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation.

Musat AI, Pigott CM, Ellis TM, Agni RM, Leverson GE, Powell AJ, Richards KR, D'Alessandro AM, Lucey MR. Musat AI, et al. Among authors: lucey mr. Liver Transpl. 2013 Oct;19(10):1132-41. doi: 10.1002/lt.23707. Epub 2013 Aug 15. Liver Transpl. 2013. PMID: 23873778 Free article.

2

Acute cellular rejection after liver transplantation: variability, morbidity, and mortality.

Fisher LR, Henley KS, Lucey MR. Fisher LR, et al. Among authors: lucey mr. Liver Transpl Surg. 1995 Jan;1(1):10-5. doi: 10.1002/lt.500010104. Liver Transpl Surg. 1995. PMID: 9346535 Free article.

3

The impact of cyclosporine dose and level on acute rejection and patient and graft survival in liver transplant recipients.

Wiesner RH, Goldstein RM, Donovan JP, Miller CM, Lake JR, Lucey MR. Wiesner RH, et al. Among authors: lucey mr. Liver Transpl Surg. 1998 Jan;4(1):34-41. doi: 10.1002/lt.500040105. Liver Transpl Surg. 1998. PMID: 9457965 Free article.

4

A prospective analysis of oxidative stress and liver transplantation.

Burke A, FitzGerald GA, Lucey MR. Burke A, et al. Among authors: lucey mr. Transplantation. 2002 Jul 27;74(2):217-21. doi: 10.1097/00007890-200207270-00012. Transplantation. 2002. PMID: 12151734

5

Induction immunosuppression in hepatitis C virus-infected liver transplant recipients.

Lucey MR. Lucey MR. Liver Transpl. 2002 Oct;8(10 Suppl 1):S44-6. doi: 10.1053/jlts.2002.35854. Liver Transpl. 2002. PMID: 12362297 Free article. No abstract available.

6

Liver transplantation at the University of Wisconsin.

Chin LT, D'Alessandro A, Knechtle S, Pirsch J, Musat A, Odorico J, Becker Y, Lucey M, Sollinger H, Kalayoglu M. Chin LT, et al. Clin Transpl. 2002:207-13. Clin Transpl. 2002. PMID: 12971451

7

Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention.

Said A, Safdar N, Lucey MR, Knechtle SJ, D'Alessandro A, Musat A, Pirsch J, Kalayoglu M, Maki DG. Said A, et al. Among authors: lucey mr. Am J Transplant. 2004 Apr;4(4):574-82. doi: 10.1111/j.1600-6143.2004.00374.x. Am J Transplant. 2004. PMID: 15023150 Free article.

8

Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.

Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR. Said A, et al. Among authors: lucey mr. J Hepatol. 2004 Jun;40(6):897-903. doi: 10.1016/j.jhep.2004.02.010. J Hepatol. 2004. PMID: 15158328

9

The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta-analysis.

Safdar N, Said A, Lucey MR. Safdar N, et al. Among authors: lucey mr. Liver Transpl. 2004 Jul;10(7):817-27. doi: 10.1002/lt.20108. Liver Transpl. 2004. PMID: 15237363 Free article. Review.

10

Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality.

Safdar N, Said A, Lucey MR, Knechtle SJ, D'Alessandro A, Musat A, Pirsch J, McDermott J, Kalayoglu M, Maki DG. Safdar N, et al. Among authors: lucey mr. Clin Infect Dis. 2004 Aug 15;39(4):517-25. doi: 10.1086/422644. Epub 2004 Aug 3. Clin Infect Dis. 2004. PMID: 15356815

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters